ClinicalTrials.gg
RecruitingNCT07667114Updated Jul 2, 2026

Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis

An observational study in Scapholunate Dissociation and Scapholunate Ligament Rupture, sponsored by Waldfriede Hospital. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by Waldfriede Hospital · Observational

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Retrospective study of patients who underwent a modified flexor carpi radialis (FCR) tenodesis for scapholunate ligament injury at Waldfriede Hospital during the period 2016-2026.

Primary outcome: Functionality of the operated wrist measured using the validated DASH questionnaire.

02

Conditions studied

  • Scapholunate Dissociation
  • Scapholunate Ligament Rupture

Keywords

  • Scapholunate ligament
  • modified flexor carpi radialis (FCR) tenodesis
  • wrist
03

In context

Lead sponsor

Waldfriede Hospital is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participation in the study is offered to all eligible patients who underwent a modified flexor carpi radialis (FCR) tenodesis for an SL ligament injury at Waldfriede Hospital between 2016 and 2026.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: ≥ 18 years
  • Capable of providing independently
  • Availability of written informed consent for the study

Exclusion criteria

Exclusion Criteria:

  • Active malignant disease
  • Pregnancy at the time of the examination
  • Presence of SLAC arthritis
  • Lack of capacity to provide independent consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • Proceduremodified flexor carpi radialis tenodesis

    Flexor carpi radialis (FCR) tenodesis for the reconstruction of the dorsal scapholunate (SL) ligament and the dorsal intercarpal ligament (DICL)

06

What researchers measure

Primary outcomes

  1. DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) questionnaire

    DISABILITIES OF THE ARM, SHOULDER AND HAND; This questionnaire asks about symptoms as well as the ability to do certain activities regarding the upper limbs. Measure uses a 0 to 100 scoring scale, where lower scores (close to 0) represent no disability, and higher scores (close to 100) indicate maximum severity or inability to perform.

    Time frame: At enrollment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Data must remain within the clinic, and we are not permitted to share the raw data publicly or upon request with external researchers as this is the standard practice for retrospective data due to data protection/GDPR

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Jan 2027, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2026
First posted
Jun 24, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Jan 31, 2027
CompletionEst.
May 31, 2027
Last update
Jul 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07667114
Lead sponsor
Waldfriede Hospital
Responsible party
Sponsor
First posted
Jun 24, 2026
Start date
Jul 1, 2026
Primary completion
Jan 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Jul 2, 2026

Study contacts

Markus Bock, Dr. med.
Contact
m.bock@waldfriede.de
+493081810200

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion